Tectonic Therapeutic, Inc.
TECX
$21.09
-$1.29-5.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 121.59% | 168.69% | 133.08% | 39.07% | 5.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.25% | 94.16% | 7.43% | -10.76% | -9.39% |
| Operating Income | -49.25% | -94.16% | -7.43% | 10.76% | 9.39% |
| Income Before Tax | -57.24% | -76.22% | -21.20% | -5.37% | 23.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -57.24% | -76.22% | -21.20% | -5.37% | 23.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57.24% | -76.22% | -21.20% | -5.37% | 23.54% |
| EBIT | -49.25% | -94.16% | -7.43% | 10.76% | 9.39% |
| EBITDA | -49.79% | -97.20% | -8.03% | 11.12% | 10.20% |
| EPS Basic | 85.79% | 84.22% | 49.00% | 10.22% | -44.46% |
| Normalized Basic EPS | 85.79% | 84.22% | 49.00% | 10.22% | -44.46% |
| EPS Diluted | 85.79% | 84.22% | 49.00% | 10.22% | -44.46% |
| Normalized Diluted EPS | 85.79% | 84.22% | 49.00% | 10.22% | -44.46% |
| Average Basic Shares Outstanding | 1,006.57% | 1,016.59% | 137.62% | 17.36% | -47.07% |
| Average Diluted Shares Outstanding | 1,006.57% | 1,016.59% | 137.62% | 17.36% | -47.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |